CCTG

CRC.9 | NRG-GI005

NCT04068103

CRC9

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Status:

Opening Soon

26459-200.png

II/III

Phase

Line of Therapy.png

Adjuvant

Line of Therapy

Disease Stage.png

Early Cancer

Disease Stage

Target.png

Biomarker(s)

N/A

Investigational

Product

n/a

Treatment Arms

o Active Comparator: Arm I (blood stored and tested for ctDNA later) - Patients undergo active surveillance.

o Experimental: Arm II (blood tested for ctDNA at baseline)